Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin

  • Thomas Forst, Peter Bramlage
  • Expert Opinion on Pharmacotherapy, May 2014, Informa Healthcare
  • DOI: 10.1517/14656566.2014.920009

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/14656566.2014.920009

The following have contributed to this page: Peter Bramlage